SurModics, Inc.
SRDX
$27.09
$0.331.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -14.96% | -9.23% | -4.91% | -7.49% | 38.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.96% | -9.23% | -4.91% | -7.49% | 38.84% |
| Cost of Revenue | 33.36% | 30.72% | 170.22% | 148.15% | 148.49% |
| Gross Profit | -24.27% | -17.80% | -22.69% | -19.46% | 27.96% |
| SG&A Expenses | 3.15% | 4.47% | 2.41% | 4.18% | -2.88% |
| Depreciation & Amortization | -0.91% | 0.00% | -1.02% | -3.61% | -7.08% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.84% | 1.24% | 0.82% | -0.66% | -3.67% |
| Operating Income | -121.52% | -114.42% | -134.71% | -618.50% | 170.27% |
| Income Before Tax | -184.23% | -199.54% | -401.81% | -504.09% | 158.96% |
| Income Tax Expenses | 39.15% | 10.14% | 0.32% | -136.19% | -42.49% |
| Earnings from Continuing Operations | -247.12% | -360.95% | -651.43% | 93.91% | 137.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -247.12% | -360.95% | -651.43% | 93.91% | 137.55% |
| EBIT | -121.52% | -114.42% | -134.71% | -618.50% | 170.27% |
| EBITDA | -83.41% | -68.74% | -52.22% | -87.76% | 254.43% |
| EPS Basic | -245.49% | -359.07% | -618.80% | 94.21% | 137.32% |
| Normalized Basic EPS | -136.47% | -136.17% | -230.59% | -686.60% | 158.37% |
| EPS Diluted | -247.73% | -366.89% | -607.28% | 93.93% | 136.93% |
| Normalized Diluted EPS | -136.50% | -136.22% | -231.20% | -664.27% | 158.33% |
| Average Basic Shares Outstanding | 0.89% | 0.88% | 0.87% | 0.86% | 0.86% |
| Average Diluted Shares Outstanding | 0.64% | 0.74% | 0.72% | 1.03% | 1.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |